Compare TRST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | CERT |
|---|---|---|
| Founded | 1902 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.9M | 860.9M |
| IPO Year | 1994 | 2020 |
| Metric | TRST | CERT |
|---|---|---|
| Price | $50.30 | $4.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 66.7K | ★ 3.0M |
| Earning Date | 04-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | 26.46 | ★ 87.50 |
| EPS | ★ 0.91 | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $54.19 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $30.17 | $4.45 |
| 52 Week High | $49.56 | $13.88 |
| Indicator | TRST | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 66.77 | 29.39 |
| Support Level | $41.96 | N/A |
| Resistance Level | N/A | $6.47 |
| Average True Range (ATR) | 0.91 | 0.31 |
| MACD | 0.06 | -0.14 |
| Stochastic Oscillator | 100.00 | 11.22 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.